【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Vaccine Approval Process
07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Global Adult and Pediatric Preventable Vaccine Market Share 2014-2019
07.4 Five Forces Analysis
08.Market Segmentation by Type of Vaccine
08.1 Live Attenuated Vaccine
08.2 Killed Vaccine
08.3 Toxoid Vaccine
08.4 Genetically Modified/Engineered Vaccine
09.Market Segmentation by Product Type
09.1 Polysaccharide Vaccines
09.2 Conjugate Vaccines
10.Geographical Segmentation
11.Global Preventable Vaccines Market by Key Geographies
11.1 Market Size and Forecast for the US
11.2 Market Size and Forecast for the EU
11.3 Market Size and Forecast for Japan
11.4 Market Size and Forecast for India
11.5 Market Size and Forecast for China
12.Global Pediatric Preventable Vaccines Market
12.1 Global Pediatric Preventable Vaccine Market
12.1.1 Market Size and Forecast
12.2 Market Segmentation of the Global Pediatric Preventable Vaccine Market
12.3 Global Pediatric Hepatitis Vaccines Market
12.3.1 Market Size and Forecast
12.4 Global Pediatric Haemophilus Influenzae Type B (Hib) Vaccines Market
12.4.1 Market Size and Forecast
12.5 Global Pediatric MMR Vaccines Market
Market Size and Forecast
12.6 Global Pediatric Combination Vaccines Market
12.6.1 Market Size and Forecast
12.7 Global Pediatric Pneumococcal Vaccines Market
12.7.1 Market Size and Forecast
12.8 Global Polio Vaccines Market
12.8.1 Market Size and Forecast
12.9 Global Pediatric Varicella Vaccines Market
12.9.1 Market Size and Forecast
12.10 Global Other Pediatric Vaccines Market
12.10.1 Market Size and Forecast
12.11 Global Pediatric Preventable Vaccines Market 2014 and 2019 (by percentage)
13.Global Adult Preventable Vaccines Market
13.1 Market Size and Forecast
13.2 Market Segmentation of the Global Adult Preventable Vaccines Market
13.3 Global Adult Cervical Vaccines Market
13.3.1 Market Size and Forecast
13.4 Global Adult Hepatitis Vaccines Market
13.4.1 Market Size and Forecast
13.5 Global Adult Influenza Vaccines Market
13.5.1 Market Size and Forecast
13.6 Global Adult Pneumococcal Vaccines Market
13.6.1 Market Size and Forecast
13.7 Global Adult Travel, Diphtheria-Tetanus, and Miscellaneous Vaccines Market
13.7.1 Market Size and Forecast
14.Key Leading Countries
14.1 US
14.2 China
14.3 Japan
14.4 India
15.Buying Criteria
16.Market Growth Drivers
17.Drivers and their Impact
18.Market Challenges
19.Impact of Drivers and Challenges
20.Market Trends
21.Trends and their Impact
22.Vendor Landscape
22.1 Competitive Scenario
22.1.1 Key News
22.1.2 Mergers and Acquisitions
22.2 Market Share Analysis 2014
22.2.1 GlaxoSmithKline
22.2.2 Merck
22.2.3 Novartis
22.2.4 Pfizer
22.2.5 Sanofi
22.3 Other Prominent Vendors
23.Key Vendor Analysis
23.1 GlaxoSmithKline
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Business Segmentation
23.1.4 Business Segmentation by Revenue 2012 and 2013
23.1.5 Sales by Geography
23.1.6 Pipeline Products
23.1.7 Business Strategy
23.1.8 Key Information
23.1.9 SWOT Analysis
23.2 Merck
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business Segmentation by Revenue 2013
23.2.4 Business Segmentation by Revenue 2012 and 2013
23.2.5 Sales by Geography
23.2.6 Business Strategy
23.2.7 Key Developments
23.2.8 SWOT Analysis
23.3 Novartis
23.3.1 Key Facts
23.3.2 Business Description
23.3.3 Business Segmentation
23.3.4 Revenue by Business Segmentation
23.3.5 Revenue Comparison 2012 and 2013
23.3.6 Sales by Geography
23.3.7 Business Strategy
23.3.8 Key Developments
23.3.9 SWOT Analysis
23.4 Pfizer
23.4.1 Key Facts
23.4.2 Business Overview
23.4.3 Business Segmentation by Revenue 2013
23.4.4 Business Segmentation by Revenue 2012 and 2013
23.4.5 Geographical Segmentation by Revenue
23.4.6 Business Strategy
23.4.7 Key Developments
23.4.8 SWOT Analysis
23.5 Sanofi
23.5.1 Key Facts
23.5.2 Business Description
23.5.3 Business Segmentation
23.5.4 Revenue by Business Segmentation
23.5.5 Revenue Comparison 2012 and 2013
23.5.6 Sales by Geography
23.5.7 Business Strategy
23.5.8 Key Developments
23.5.9 SWOT Analysis
24.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Vaccine Approval Process
Exhibit 3: Global Preventable Vaccines Market 2014-2019 (US$ million)
Exhibit 4: Global Preventable Vaccines Market Categories
Exhibit 5: Global Adult and Pediatric Preventable Vaccine Market Share 2014-2019 (US$ million)
Exhibit 6: Global Preventable Vaccines Market Share by Vaccine Type 2014 and 2019
Exhibit 7: Global Preventable Vaccines Market Segmentation by Type of Vaccine
Exhibit 8: Global Preventable Vaccines Market Segmentation by Product Type
Exhibit 9: Global Preventable Vaccines Market by Geographical Segmentation 2014
Exhibit 10: Global Preventable Vaccines Market by Region 2014-2019 (US$ million)
Exhibit 11: Global Preventable Vaccines Market in the US 2014-2019 (US$ million)
Exhibit 12: Global Preventable Vaccines Market in the EU 2014-2019 (US$ million)
Exhibit 13: Global Preventable Vaccines Market in Japan 2014-2019 (US$ million)
Exhibit 14: Global Preventable Vaccines Market in India 2014-2019 (US$ million)
Exhibit 15: Global Preventable Vaccines Market in China 2014-2019 (US$ million)
Exhibit 16: Global Pediatric Preventable Vaccines Market 2014-2019 (US$ million)
Exhibit 17: Global Pediatric Preventable Vaccines Market Segmentation
Exhibit 18: Global Pediatric Hepatitis Vaccines Market 2014-2019 (US$ million)
Exhibit 19: Global Pediatric Haemophilus Influenzae Type B Vaccines Market 2014-2019 (US$ million)
Exhibit 20: Global Pediatric MMR Vaccine Market 2014-2019 (US$ million)
Exhibit 21: Global Pediatric Combination Vaccines Market 2014-2019 (US$ million)
Exhibit 22: Global Pediatric Pneumococcal Vaccines Market 2014-2019 (US$ million)
Exhibit 23: Global Polio Vaccines Market 2014-2019 (US$ million)
Exhibit 24: Global Pediatric Varicella Vaccines Market 2014-2019 (US$ million)
Exhibit 25: Global Other Pediatric Vaccines Market 2014-2019 (US$ million)
Exhibit 26: Global Pediatric Preventable Vaccines Market by Vaccine Segmentation (2014 and 2019) (US$ Million)
Exhibit 27: Global Pediatric Preventable Vaccines Market by Vaccine Segmentation 2014 (in %)
Exhibit 28: Global Pediatric Preventable Vaccines Market by Vaccine Segmentation 2019 (in %)
Exhibit 29: Snapshot of Global Pediatric Preventable Vaccines Market by Segments 2014-2019
Exhibit 30: Global Adult Preventable Vaccines Market 2014-2019 (US$ million)
Exhibit 31: Global Adult Cervical Vaccines Market 2014-2019 (US$ million)
Exhibit 32: Global Adult Hepatitis Vaccines Market 2014-2019 (US$ million)
Exhibit 33: Global Adult Influenza Vaccine Market 2014-2019 (US$ million)
Exhibit 34: Global Adult Pneumococcal Vaccines Market 2014-2019 (US$ million)
Exhibit 35: Global Travel, Diphtheria-Tetanus, and Miscellaneous Vaccines Market 2014-2019 (US$ million)
Exhibit 36: Global Adult Preventable Vaccines Market by Vaccine Segmentation (2014 and 2019) (US$ Million)
Exhibit 37: Global Adult Preventable Vaccines Market by Vaccine Segmentation 2014 (in %)
Exhibit 38: Global Adult Preventable Vaccines Market by Vaccine Segmentation 2019 (in %)
Exhibit 39: Snapshot of Global Adult Preventable Vaccines Market by Segments 2014-2019
Exhibit 40: Buying Criteria of the Global Preventable Vaccines Market
Exhibit 41: Drivers and their Impact on the Key Customer Category of the Global Preventable Vaccines Market
Exhibit 42: Drivers and their Impact on Geographies in Global Preventable Vaccines Market
Exhibit 43: GlaxoSmithKline’s Revenue 2013
Exhibit 44: GlaxoSmithKline: Vaccine Pipeline
Exhibit 45: Merck’s Revenue 2013
Exhibit 46: Novartis’ Revenue 2013
Exhibit 47: Novartis: Vaccine Pipeline
Exhibit 48: Pfizer’s Revenue 2013
Exhibit 49: Sanofi’s Revenue 2013
Exhibit 50: GlaxoSmithKline: Business Segmentation 2013
Exhibit 51: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 52: GlaxoSmithKline: Sales by Geography 2013
Exhibit 53: GlaxoSmithKline: Pipeline Products 2013
Exhibit 54: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 55: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 56: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 57: Novartis AG: Business Segmentation
Exhibit 58: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 59: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 60: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 61: Pfizer: Business Segmentation by Revenue 2013
Exhibit 62: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 63: Pfizer: Geographical Segmentation by Revenue 2013
Exhibit 64: Sanofi SA: Business Segmentation
Exhibit 65: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 66: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 67: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル：予防ワクチンの世界市場：弱毒生ワクチン、死菌ワクチン、トキソイドワクチン、遺伝子組み換えワクチン■ 英文：Global Preventable Vaccines Market 2015-2019
■ 発行日：2015年2月18日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5256
■ 調査対象地域：グローバル
- FMCG（日用消費財）製品包装の世界市場：食品・飲料パッケージ、家庭用品・タバコパッケージ、医薬品パッケージ、化粧品・ケア製品パッケージAbout FMCG Packaging FMCG are fast moving consumer goods that are present in retail, supermarket, and local retail shops. These are physical goods that are produced and purchased to satisfy the needs of consumers. Some of its key segments are Food, Beverages, Healthcare and Medical, Cosmetics, Industrial Goods, Household Products, and Other Goods that consumers use in daily life. Food products, be …
- 再発性悪性神経膠腫(Recurrent Malignant Glioma)：世界の治験レビュー（2015年上半期版）Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2015" provides data on the Recurrent Malignant Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Recurrent Malignant Glioma. It includes an overview of the t …
- 液体屋根材の世界市場：PU塗料、アクリル塗料、PU/アクリル・ハイブリッド、歴青質塗料、シリコーン塗料、変性シラン・ポリマー、EPDMゴム、エラストマ膜、セメント系膜The market size of liquid roofing is projected to reach USD 7.48 Billion by 2021, at a CAGR of 7.1%. It is projected to be 3,439.3 million square meters by 2021, registering a CAGR of 6.7% between 2016 and 2021. The growing construction industry, increasing demand for energy-efficient buildings, and continuous new product launch/development, agreement/collaboration, expansion, and merger & acquisi …
- 世界の免疫測定システム市場動向（2012-2016）TechNavio’s analysts forecast the Global Immunoassay Systems market to grow at a CAGR of 3.92 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased prevalence of chronic diseases worldwide. The Global Immunoassay Systems market has also been witnessing a growing popularity of portable immunoassays. However, limited reimbursements could pose a …
- Transplantation：グローバル臨床試験レビューH1, 2013Transplantation Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Transplantation Global Clinical Trials Review, H1, 2013" provides data on the Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Transplantation. It includes an overview of the trial numbers and their recruitment status as …
- 次世代バイオロジックス（生物製剤）市場：技術、産業、市場（2014-2024）Emerging biological drugs – discover R&D, business analysis, and revenue forecasts What’s the future of biologics, especially new drug classes? Now get the latest technological and commercial analysis. Staying ahead in data and knowledge, you benefit your authority. And you explore trends, developments, results, opportunities, and sales predictions. So visiongain’s new report shows you what’s poss …
- 病院用EMR（電子カルテ）システムの世界市場予測（～2023年）“The hospital electronic medical record (EMR) market is projected to grow at a CAGR of 8.8%.”The global hospital electronic medical records market is valued at an estimated USD 12.0 billion in 2018 and is projected to reach USD 18.3 billion by 2023, at a CAGR of 8.8% during the forecast period. The key factors driving the growth of this market include the government support for the adoption of EMR …
- 世界の企業検索市場（2012-2016）TechNavio's analysts forecast the Global Enterprise Search market to grow at a CAGR of 12.98 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for rapid and easy data access. The Global Enterprise Search market has also been witnessing the emergence of software-as-a-service based solutions. However, the high cost of implementation …
- ワークプレイス変革の世界市場予測（～2021年）“Increasing trend in the adoption of new technologies such as Bring Your Own Device (BYOD) and enterprise mobility by organizations is driving the growth of the workplace transformation market” MarketsandMarkets: The workplace transformation market size is estimated to grow from USD 8.02 billion in 2016 to USD 18.06 billion by 2021, at a CAGR of 17.6%. Increasing trend in the adoption of new techn …
- 飲料用安定剤の世界市場：製品種類別（アラビアゴム、カルボキシメチルセルロース、キサンタンガム、カラギーナン、ペクチンなど）、飲料種類別（果物飲料、乳製品飲料、清涼飲料、アルコール飲料、その他）Beverage stabilizers can be defined as food additives that prevents degradation in beverages and help in maintaining consistency by keeping additional ingredients suspended in the solution for a longer period of time. Modified starch, pectin, carrageenan, casein inulin, and hydrocolloids are among the most commonly used beverage stabilizers. There is a substantial increase in the worldwide demand …
- 電気ヒートトレースの世界市場予測（～2023年）The electric heat tracing (EHT) market is expected to be valued at USD 3.26 Billion by 2023, growing at a CAGR of 5.3% between 2017 and 2023. The growth of this market can be attributed to the increasing demand for energy-efficient electric heat tracing systems, low maintenance cost, and high adoption of electric heat tracing systems over conventional systems. This report segments the electric hea …
- 超音波画像診断：グローバル市場分析と予測MediPoint: Diagnostic Ultrasound Imaging - Global Analysis and Market Forecasts Summary An early diagnosis of disease is the foundation for increasing survival rates. Diagnostic ultrasound imaging is the most widely used technique to achieve early detection and clinical assessment of adult and pediatric patients alike, making it a cornerstone of disease control. This report provides an analysis of …
- 心臓補助装置：製品分析MediPoint: Cardiac Assist Devices - Current and Pipeline Products Summary While heart transplantation remains the gold standard and preferred treatment option for patients with advanced Congestive Heart Failure (CHF), the number of transplant candidates far exceeds the donor pool. This significant limitation has prompted considerable, continued interest in the development of Cardiac Assist Devices …
- モジュール建設（モジュール工法）の世界市場予測（～2023年）MarketsandMarkets projects that the modular construction market will grow from USD 92.18 billion in 2018 to USD 129.67 billion by 2023, at a CAGR of 7.1%. Growth in infrastructure investment and industrialization, ease of installation and relocation, and the demand for affordable housing drive the growth of the modular construction market. The housing segment is projected to account for a larger s …
- ポリメタクリル酸メチル樹脂（PMMA）の世界市場2015-2019About polymethyl methacrylate Polymethyl methacrylate is a synthetic resin produced by the polymerization of methyl methacrylate. It is a clear acrylic material and can be used to replace glass in different products, such as electronic products and furniture. Since polymethyl methacrylate is a linear thermoplastic polymer, it possess high mechanical strength and is also highly scratch resistant. T …
